Episode 1: Setting the Record Straight on Obesity and Type 2 Diabetes Medications

Resources for the Community: ___________________________________________________________________ Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55 Ro GLP-1 Insurance Checker https://ro.co/weight-loss/glp1-insurance-checker/ Ro GLP-1 Supply and Shortage Tracker https://ro.co/weight-loss/supply-tracker/ Learn more about Obesity https://www.obesityaction.org/ ______________________________________________________________________ In this episode, we discuss the common misconceptions surrounding prescribing GLP1 medications such as Ozempic, Victoza, and Mounjaro, which were initially designed to treat type 2 diabetes and are now being prescribed to treat the disease of obesity. Dr. Michael Albert, an obesity specialist, joins us to set the record straight. ______________________________________________________________________ ⭐️Mounjaro Stanley⭐️ griffintumblerco.Etsy.com Use code PODCAST10 for $ OFF ______________________________________________________________________ Join this channel to get access to perks: / @theplussidez ______________________________________________________________________ #Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy Send us Fan Mail! Support the show Kim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==